ATE378408T1 - Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren - Google Patents

Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren

Info

Publication number
ATE378408T1
ATE378408T1 AT99969114T AT99969114T ATE378408T1 AT E378408 T1 ATE378408 T1 AT E378408T1 AT 99969114 T AT99969114 T AT 99969114T AT 99969114 T AT99969114 T AT 99969114T AT E378408 T1 ATE378408 T1 AT E378408T1
Authority
AT
Austria
Prior art keywords
seq
ztgfss9
mammal
growth factor
transforming growth
Prior art date
Application number
AT99969114T
Other languages
English (en)
Inventor
Scott Presnell
David Taft
Kevin Foley
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE378408T1 publication Critical patent/ATE378408T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99969114T 1998-09-17 1999-09-17 Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren ATE378408T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15481798A 1998-09-17 1998-09-17

Publications (1)

Publication Number Publication Date
ATE378408T1 true ATE378408T1 (de) 2007-11-15

Family

ID=22552920

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99969114T ATE378408T1 (de) 1998-09-17 1999-09-17 Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren

Country Status (11)

Country Link
EP (2) EP1897948A1 (de)
JP (2) JP2002525056A (de)
AT (1) ATE378408T1 (de)
AU (1) AU6050499A (de)
CA (2) CA2706859A1 (de)
DE (1) DE69937570T2 (de)
DK (1) DK1114156T3 (de)
ES (1) ES2300154T3 (de)
IL (1) IL141869A0 (de)
WO (1) WO2000015798A2 (de)
ZA (1) ZA200101819B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060127A2 (en) 1998-05-15 1999-11-25 Genentech, Inc. Il-17 homologous polypeptides and therapeutic uses thereof
US6562578B1 (en) 1999-01-11 2003-05-13 Schering Corporation IL-17-like cytokine binding compounds and antibodies
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
EP1443055A3 (de) * 1998-05-29 2005-06-08 Human Genome Sciences, Inc. Interleukine-21 und 22
IL143600A0 (en) * 1999-01-11 2002-04-21 Schering Corp Interleukin-17 related mammalian cytokines, polynucleotides encoding them and their uses
EP2290081A3 (de) * 1999-12-23 2012-08-01 Genentech, Inc. IL-17-homologe Polypeptide und ihre therapeutische Verwendung
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030166268A1 (en) * 2000-05-31 2003-09-04 Holloway James L. Mammalian transforming growth factor beta-10
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2002044379A2 (en) * 2000-11-28 2002-06-06 Amgen, Inc. Transforming growth factor-beta-related molecules and uses thereof
EP1359938B1 (de) 2001-01-25 2011-03-16 ZymoGenetics, Inc. Verfahren zur behandlung von psoriasis unter verwendung eines il-17d antagonisten
AU2002318513A1 (en) * 2001-07-06 2003-01-21 Nsgene A/S Novel neurotrophic factors
GB0417487D0 (en) 2004-08-05 2004-09-08 Novartis Ag Organic compound
WO2008058251A1 (en) * 2006-11-08 2008-05-15 Zymogenetics, Inc. Variants and methods of using transforming growth factor beta-9
US20090317400A1 (en) 2008-05-05 2009-12-24 Krzysztof Masternak Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof
MX2011011729A (es) 2009-05-05 2012-04-10 Novimmune Sa Anticuerpo anti il-17f y metodos de uso de los mismos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532159A (en) * 1994-04-01 1996-07-02 The Ohio State University Monoclonal antibody to canine placental oncofetal protein for detecting cancer
DK0839196T3 (da) * 1995-07-19 2005-09-12 Inst Genetics Llc Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
ES2223127T3 (es) * 1997-04-25 2005-02-16 Zymogenetics, Inc. Factor 7 mamario del tipo citoquina.
US20030003545A1 (en) 1998-05-29 2003-01-02 Reinhard Ebner Interleukins-21 and 22
IL143600A0 (en) 1999-01-11 2002-04-21 Schering Corp Interleukin-17 related mammalian cytokines, polynucleotides encoding them and their uses

Also Published As

Publication number Publication date
CA2343569C (en) 2010-09-14
DE69937570D1 (de) 2007-12-27
AU6050499A (en) 2000-04-03
JP2010187691A (ja) 2010-09-02
EP1114156A2 (de) 2001-07-11
IL141869A0 (en) 2002-03-10
DE69937570T2 (de) 2009-04-23
WO2000015798A2 (en) 2000-03-23
WO2000015798A3 (en) 2000-05-25
DK1114156T3 (da) 2008-03-03
CA2343569A1 (en) 2000-03-23
ZA200101819B (en) 2001-09-27
ES2300154T3 (es) 2008-06-01
CA2706859A1 (en) 2000-03-23
EP1114156B1 (de) 2007-11-14
EP1897948A1 (de) 2008-03-12
JP2002525056A (ja) 2002-08-13

Similar Documents

Publication Publication Date Title
ATE378408T1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
DK0839196T3 (da) Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
IL210455A0 (en) Novel cytokine zcytor17 ligand
ATE269902T1 (de) Cytokinähnliches polypeptid-10 aus säugetieren
DK1294888T3 (da) Interferonlignende protein Zcyto21
HK1078093A1 (en) Antibodies against fibroblast growth factor 23
ATE536409T1 (de) Unkrautbekämpfungsstoffwechselproteine, gene dafür und ihre verwendung
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
CY1111763T1 (el) ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51
DE69929454D1 (de) Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
EA200100440A1 (ru) Ген prv-1 и его применение
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
NZ606260A (en) Novel polypeptides involved in immune response

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1114156

Country of ref document: EP